Significant growth trajectory of the Breast Cancer Application segment, which is expected to reach US$374.1 Million by 2030 ...

Doxorubicin HCl 10mg/vial, 20mg/vial, 50mg/vial; pwd for IV inj after reconstitution; contains lactose. Risk of cardiomyopathy (including left ventricular failure), arrhythmias. Pre-existing heart ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

In view of the patient's long progression-free survival (12.9 months), we decided to resume intramuscular octreotide (30 mg every 3 weeks) with capecitabine and liposomal doxorubicin chemotherapy ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

Monopar Therapeutics Inc.’s MNPR share price has surged by 24.76%, which has investors questioning if this is right time to ...

A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read ...

Discover all the brand names or Trade names of generic drug called Doxorubicin. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal ...